SlideShare a Scribd company logo
KANA ENSEFALITI DIAGNOSTIKASI
ABDURAKHIMOV AKRAMJON
Toshkent tibbiyot akademiyasi
DIAGNOSTIKA
• Birinchi faza leykotsitlar miqdorining kamayishi (leykopeniya), trombotsitlar
miqdorining kamayishi (trombositopeniya). Jigar fermentlari biroz ko‘tarilgan
bo‘lishi mumkin.
• Ikkinchi faza nevrologik kasallikning boshlanishi, qon va orqa miya suyuqligida
leykotsitlar miqdorining oshishi.
 Virusni ajratib olish, birinchi fazada qondan va ikkinchi fazada orqa miya
suyuqligidan.
 Biroz pleositoz va orqa miya suyuqligida albuminning oshishi.
Laborator diagnostika
• Laborator diagnostika uchun odatda serologiya ishlatiladi.
ELISA usulida IgMni ajratish, zardob yoki orqa miya
suyuqligidan..
• Virusni ajratib olish yoki RT-PZR
• MRT 15-20% bemorlarda buzilishlarni beradi.
• EEG 75% bemorlarda normal bo‘lmaydi.
DAVOLASH
• Spesifik antivirus terapiya mavjud emas.
• Davolash qo‘llab-quvvatlovchi va
simptomatik davodan iborat.
• Odatda intubatsiya and kortikosteroidlar
ishlatiladi
• MNS depressantlari, analgetiklar.
OLDINI OLISH
• Sayohatga borganda kundalik mahsulotlarni
pasterizatsiyalanmagan holatda iste’mol qilmaslik
• Hasharot repellentlarini ishlatish va himoyalovchi
kiyimlar kiyish, kana chaqishini oldini olish uchun.
• Ko‘pincha kimyoviy DEET (dietiltoluamid)hasharot
repellenti sifatida ishlatiladi
• Ochiq rangdagi kiyimlar kiyish, shunda kanani
ko‘rish va ajratish oson bo‘ladi.
• Kiyimlar va kemping ashyolari permethrin saqlovchi
moddalar bilan ishlanishi mumkin, unda akarisidal va
repellent effekti bor.
Vaksina
• AQSHda kana ensefalitiga qarshi vaksinalar ro‘yhatga
olinmagan.
• Yevropada inaktivatsiyalangan hujayra
kulturalaridan olingan ikkita vaksina mavjud,
kattalar va bolalar uchun dozalangan.
• Rossiyada boshqa ikkita inaktivatsiyalangan vaksina
mavjud.
Kana ensefaliti

More Related Content

What's hot

Stefan cel Mare
Stefan cel MareStefan cel Mare
Stefan cel Mare
Angesha
 
Plasmodium Disease
Plasmodium Disease Plasmodium Disease
Plasmodium Disease
thirupathiSathya
 

What's hot (20)

Typhus: the Rickettsial Disease
Typhus: the Rickettsial DiseaseTyphus: the Rickettsial Disease
Typhus: the Rickettsial Disease
 
Amoeba
AmoebaAmoeba
Amoeba
 
Lymphoid organs
Lymphoid organs Lymphoid organs
Lymphoid organs
 
Leischmaniasis (Kala Azar)
Leischmaniasis (Kala Azar)Leischmaniasis (Kala Azar)
Leischmaniasis (Kala Azar)
 
Plasmodium
PlasmodiumPlasmodium
Plasmodium
 
Ribosome ultra structure
Ribosome ultra structureRibosome ultra structure
Ribosome ultra structure
 
Stefan cel Mare
Stefan cel MareStefan cel Mare
Stefan cel Mare
 
MAJOR HISTOCOMPATIBILITY COMPLEX
MAJOR HISTOCOMPATIBILITY COMPLEXMAJOR HISTOCOMPATIBILITY COMPLEX
MAJOR HISTOCOMPATIBILITY COMPLEX
 
Chloroplast
ChloroplastChloroplast
Chloroplast
 
Nuclear envelope and nuclear lamina
Nuclear envelope and nuclear lamina Nuclear envelope and nuclear lamina
Nuclear envelope and nuclear lamina
 
Leishmaniasis
LeishmaniasisLeishmaniasis
Leishmaniasis
 
Primary and secondary lymphoid organs
Primary and secondary lymphoid organsPrimary and secondary lymphoid organs
Primary and secondary lymphoid organs
 
Introductory parasitology 2020
Introductory parasitology 2020Introductory parasitology 2020
Introductory parasitology 2020
 
COVID 19- Diagnosis and Treatment
COVID 19- Diagnosis and TreatmentCOVID 19- Diagnosis and Treatment
COVID 19- Diagnosis and Treatment
 
Plasmodium Disease
Plasmodium Disease Plasmodium Disease
Plasmodium Disease
 
Nucleus
NucleusNucleus
Nucleus
 
Lysosome - Basics
Lysosome - BasicsLysosome - Basics
Lysosome - Basics
 
Features of structure of Spirochetes, Rickettsia, Chlamydia, Mycoplasmas, Act...
Features of structure of Spirochetes, Rickettsia, Chlamydia, Mycoplasmas, Act...Features of structure of Spirochetes, Rickettsia, Chlamydia, Mycoplasmas, Act...
Features of structure of Spirochetes, Rickettsia, Chlamydia, Mycoplasmas, Act...
 
Balantidium coli
Balantidium coliBalantidium coli
Balantidium coli
 
Toxoplasma gondii
Toxoplasma gondiiToxoplasma gondii
Toxoplasma gondii
 

Kana ensefaliti

  • 1. KANA ENSEFALITI DIAGNOSTIKASI ABDURAKHIMOV AKRAMJON Toshkent tibbiyot akademiyasi
  • 2. DIAGNOSTIKA • Birinchi faza leykotsitlar miqdorining kamayishi (leykopeniya), trombotsitlar miqdorining kamayishi (trombositopeniya). Jigar fermentlari biroz ko‘tarilgan bo‘lishi mumkin. • Ikkinchi faza nevrologik kasallikning boshlanishi, qon va orqa miya suyuqligida leykotsitlar miqdorining oshishi.  Virusni ajratib olish, birinchi fazada qondan va ikkinchi fazada orqa miya suyuqligidan.  Biroz pleositoz va orqa miya suyuqligida albuminning oshishi.
  • 3. Laborator diagnostika • Laborator diagnostika uchun odatda serologiya ishlatiladi. ELISA usulida IgMni ajratish, zardob yoki orqa miya suyuqligidan.. • Virusni ajratib olish yoki RT-PZR • MRT 15-20% bemorlarda buzilishlarni beradi. • EEG 75% bemorlarda normal bo‘lmaydi.
  • 4. DAVOLASH • Spesifik antivirus terapiya mavjud emas. • Davolash qo‘llab-quvvatlovchi va simptomatik davodan iborat. • Odatda intubatsiya and kortikosteroidlar ishlatiladi • MNS depressantlari, analgetiklar.
  • 5. OLDINI OLISH • Sayohatga borganda kundalik mahsulotlarni pasterizatsiyalanmagan holatda iste’mol qilmaslik • Hasharot repellentlarini ishlatish va himoyalovchi kiyimlar kiyish, kana chaqishini oldini olish uchun. • Ko‘pincha kimyoviy DEET (dietiltoluamid)hasharot repellenti sifatida ishlatiladi • Ochiq rangdagi kiyimlar kiyish, shunda kanani ko‘rish va ajratish oson bo‘ladi. • Kiyimlar va kemping ashyolari permethrin saqlovchi moddalar bilan ishlanishi mumkin, unda akarisidal va repellent effekti bor.
  • 6. Vaksina • AQSHda kana ensefalitiga qarshi vaksinalar ro‘yhatga olinmagan. • Yevropada inaktivatsiyalangan hujayra kulturalaridan olingan ikkita vaksina mavjud, kattalar va bolalar uchun dozalangan. • Rossiyada boshqa ikkita inaktivatsiyalangan vaksina mavjud.